Clinical Trial Update: Cardiovascular Effects of Metformin on Obesity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating cardiovascular effects of metformin on obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Insulin Resistance | Phase 4 | Status: WITHDRAWN